Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us

Download Mobile App




Canadian Researchers Find Gene Linked to Aging

By LabMedica International staff writers
Posted on 03 Aug 2009
Canadian scientists have discovered a gene that may play a role in skin aging. More...
Researchers were investigating the genetic cause of a rare disorder known as cutis laxa type 2 (CL2), which causes skin on the feet, hands, and face to be loose and older looking, as well as growth and developmental delays including effects on the brain. In the process, researchers found some interesting correlations with the synthesis of proline, a chemical associated with skin and joint health.

The findings were published in the July 1, 2009, online issue of American Journal of Human Genetics, and are part of the Atlantic Medical Genetic and Genomics Initiative (AMGGI), an ambitious, multipartner gene-discovery project, managed by Genome Atlantic (Halifax, NS, Canada).

Several Maritime Canadian families with CL2 were identified by clinicians at the IWK Health Center's Maritime Medical Genetics service. Through genomic research, scientists were able to identify the gene responsible for CL2 in these patients, referring to an interruption of the metabolism of the amino acid, proline. The gene, pyrroline-5-carboxylate reductase 1, carries out the final step of proline synthesis.

Proline is a key component of connective tissue and skin proteins, collagen, and elastin. It can be created by the body, and is also found in our diets. Some skin creams, cosmetics, and vitamin supplements already include proline, hyping its health benefits. However, proline is not completely understood. Researchers know that it helps make ‘kinks' in protein chains, crucial for correct folding of these proteins. But it seems to play an independent role in protection from cellular stress. Proline made internally in bodies may have a biologic role distinct from that of dietary proline.

"This reinforces our understanding of proline as an integral part of skin health,” said Dr. Mark Samuels, AMGGI co-lead. "It provides the impetus for further work that could help us understand the development of skin, the largest, and one of the most complex organs of the body. It shows that you can't mess with proline without causing a dramatic effect on many systems, including brain development.”

The gene is one of six novel discoveries made to date through the AMGGI project. Among them, a gene related to sudden cardiac death and one linked to hemoglobin production.

Related Links:
Atlantic Medical Genetic and Genomics Initiative
Genome Atlantic



Gold Member
Hybrid Pipette
SWITCH
POC Helicobacter Pylori Test Kit
Hepy Urease Test
Sample Transportation System
Tempus1800 Necto
ESR Analyzer
TEST1 2.0
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Molecular Diagnostics

view channel
Image: The diagnostic device can tell how deadly brain tumors respond to treatment from a simple blood test (Photo courtesy of UQ)

Diagnostic Device Predicts Treatment Response for Brain Tumors Via Blood Test

Glioblastoma is one of the deadliest forms of brain cancer, largely because doctors have no reliable way to determine whether treatments are working in real time. Assessing therapeutic response currently... Read more

Immunology

view channel
Image: Circulating tumor cells isolated from blood samples could help guide immunotherapy decisions (Photo courtesy of Shutterstock)

Blood Test Identifies Lung Cancer Patients Who Can Benefit from Immunotherapy Drug

Small cell lung cancer (SCLC) is an aggressive disease with limited treatment options, and even newly approved immunotherapies do not benefit all patients. While immunotherapy can extend survival for some,... Read more

Microbiology

view channel
Image: New evidence suggests that imbalances in the gut microbiome may contribute to the onset and progression of MCI and Alzheimer’s disease (Photo courtesy of Adobe Stock)

Comprehensive Review Identifies Gut Microbiome Signatures Associated With Alzheimer’s Disease

Alzheimer’s disease affects approximately 6.7 million people in the United States and nearly 50 million worldwide, yet early cognitive decline remains difficult to characterize. Increasing evidence suggests... Read more

Technology

view channel
Image: Vitestro has shared a detailed visual explanation of its Autonomous Robotic Phlebotomy Device (photo courtesy of Vitestro)

Robotic Technology Unveiled for Automated Diagnostic Blood Draws

Routine diagnostic blood collection is a high‑volume task that can strain staffing and introduce human‑dependent variability, with downstream implications for sample quality and patient experience.... Read more

Industry

view channel
Image: Roche’s cobas® Mass Spec solution enables fully automated mass spectrometry in routine clinical laboratories (Photo courtesy of Roche)

New Collaboration Brings Automated Mass Spectrometry to Routine Laboratory Testing

Mass spectrometry is a powerful analytical technique that identifies and quantifies molecules based on their mass and electrical charge. Its high selectivity, sensitivity, and accuracy make it indispensable... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.